Evidence map›Paper›PMID 36409206›Full record

ArticleLuminescence : the journal of biological and chemical luminescence2023

Copper-mediated oxidation of imidazopyrazinones inhibits marine luciferase activity.

Justin J O'Sullivan, Vanessa J Lee, Marie C Heffern

Open access · greenAbstract read
In one paragraph

Article in Luminescence : the journal of biological and chemical luminescence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Justin J O'SullivanDepartment of Chemistry, UC Davis, One Shields Avenue, Davis, CA, United States.ORCID https://orcid.org/0000-0003-0264-7783
Vanessa J LeeDepartment of Chemistry, UC Davis, One Shields Avenue, Davis, CA, United States.
Marie C HeffernDepartment of Chemistry, UC Davis, One Shields Avenue, Davis, CA, United States.ORCID https://orcid.org/0000-0001-7501-2741
University of California, Davis · US

Funding

Supplement: Metalloendocrinology: Mapping Bioinorganic Chemistry in the Extracellular SpaceR35GM133684 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HEFFERN, MARIE C. · 2019 to 2023
$2.0M
Epigenetic regulation of Wilson DiseaseR01DK104770 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MEDICI, VALENTINA · 2016 to 2020
$1.8M
NIDDK NIH HHS R01 DK104770NIGMS NIH HHS R35 GM133684
6 · The paper itself

Abstract

The development of bioluminescence-based tools has seen steady growth in the field of chemical biology over the past few decades ranging in uses from reporter genes to assay development and targeted imaging. More recently, coelenterazine-utilizing luciferases such as Gaussia, Renilla, and the engineered nano-luciferases have been utilized due to their intense luminescence relative to firefly luciferin/luciferase. The emerging importance of these systems warrants investigations into the components that affect their light production. Previous work has reported that one marine luciferase, Gaussia, is potently inhibited by copper salt. The mechanism for inhibition was not elucidated but was hypothesized to occur via binding to the enzyme. In this study, we provide the first report of a group of nonhomologous marine luciferases also exhibiting marked decreases in light emission in the presence of copper (II). We investigate the mechanism of action behind this inhibition and demonstrate that the observed copper inhibition does not stem from a luciferase interaction but rather the chemical oxidation of imidazopyrazinone luciferins generating inert, dehydrated luciferins.

Indexed as

CopperLuciferases, FireflyFirefly LuciferinLuciferasesLuminescenceLuminescent MeasurementsOxidation-ReductionCopperFirefly LuciferinLuciferasesLuciferases, Fireflybioluminescencecopperimidazopyrazinonemarine luciferasemarine luciferin

Identifiers

PMID36409206
PMCPMC10281456
OpenAlexW4309511335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.